ZoeNCure Therapeutics
PrivateLast Round
Seed
Sep 3, 2026
Total Funding Raised
$2.7M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
ZoeNCure Therapeutics is an oncology biotechnology company that develops high-potency targeted cancer therapies, including next-generation antibody-drug conjugates (ADCs) and cell therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ZoeNCure Therapeutics Comparables
Compare ZoeNCure Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Styx Biotechnologies, Inc. | 77% | |
| Mestastop Solutions | 75% | |
| Zumutor Biologics | 63% |
For institutional investors. Book with your work email.
ZoeNCure Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 3, 2026 |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 3, 2026
$2.4M round led by Tyagi Family.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_financingSep 3, 2026
ZoeNCure receives a $2.12M Seed investment in India on Sep 3rd '26 to accelerate its next-generation antibody drug conjugate (ADC) program.
- receives_financingSep 3, 2026
ZoeNCure receives a $265K Pre Seed investment from the Tyagi Family to initiate its operations.
For institutional investors. Book with your work email.
ZoeNCure Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ZoeNCure Therapeutics's valuation, stock price, and market status.
Is ZoeNCure Therapeutics a public or private company?
ZoeNCure Therapeutics is a private company.
What is the current stock price of ZoeNCure Therapeutics?
ZoeNCure Therapeutics is a private company, so its shares have no public market price. Caplight tracks ZoeNCure Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ZoeNCure Therapeutics worth (valuation)?
Valuation information for ZoeNCure Therapeutics is not publicly available.
Can I buy ZoeNCure Therapeutics stock?
ZoeNCure Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ZoeNCure Therapeutics's last funding round?
ZoeNCure Therapeutics's most recent funding round was Seed on September 3, 2026.
Who are the main investors in ZoeNCure Therapeutics?
Investor information for ZoeNCure Therapeutics is not publicly disclosed.
Will ZoeNCure Therapeutics IPO soon?
No public IPO plans have been announced for ZoeNCure Therapeutics.
How can I track ZoeNCure Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in ZoeNCure Therapeutics's shares on secondary markets.